After two-year hiatus
IA launches review into equity income sector
Over the past decade, sector classification issues have proved a persistent thorn in the side of the Investment Association (and predecessor the IMA).
The pharmaceutical and biotechnology sector has performed well in recent years, primarily by virtue of attractive fundamentals.
Another UK Equity Income fund to be ejected
Firms asked if other income sectors require change
How have they performed?
One-year yield falling short of requirements
Avoid 'optically-high' yields
Based on Capital Economics report
Oil, industrials and banks dividends at risk
Net sales down 19%
UK Value Opps approaching £800m
Managers bullish on UK consumer
Fund outperforms index over month
With some companies unable to generate the necessary earnings growth to continue increasing dividends, Gervais Williams, manager of the Miton MicroCap trust, explores the options for investors to ensure their portfolios continue to generate a rising income
Armour to retire at end of 2016
Company's first annual results
Strategy reaches £1.5bn
Exposure to dividend-yielding stocks
Strategy AUM reaches £1.3bn
Buying BHP and Rio Tinto
Plans to return to role
Tobacco and pharmaceuticals take biggest hit